其他
Virios(VIRI)02-28 05:35
$Virios(VIRI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-001844 Act: 34 Size: 40 KB 网页链接
简介:Virios Therapeutics, Inc.是一家处于发展阶段的生物技术公司,致力于开发新型抗病毒疗法,以治疗与病毒触发的异常免疫反应相关的疾病。
今开:0.3585 | 昨收:0.3541 |
最高:0.3934 | 最低:0.345584 |
涨停价: | 跌停价: |
总市值:7354606 |
Virios(VIRI)02-28 05:35
$Virios(VIRI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-001844 Act: 34 Size: 40 KB 网页链接
Virios(VIRI)02-29 02:05
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005676 Size: 5 KB 网页链接
Virios(VIRI)04-30 05:35
$Virios(VIRI)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-054204 Act: 34 Size: 12 MB 网页链接
Virios(VIRI)05-09 20:05
$Virios(VIRI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-007474 Act: 34 Size: 294 KB 网页链接
Virios(VIRI)02-29 02:15
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005684 Size: 5 KB 网页链接
Virios(VIRI)02-29 02:25
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005686 Size: 5 KB 网页链接
Virios(VIRI)03-07 05:35
$Virios(VIRI)$ 8-K Current report, item 5.07 Accession Number: 0001558370-24-002613 Act: 34 Size: 175 KB 网页链接
Virios(VIRI)03-01 22:15
$Virios(VIRI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002239 Act: 34 Size: 5 MB 网页链接
Virios(VIRI)02-29 01:55
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005674 Size: 5 KB 网页链接
Virios(VIRI)02-29 02:05
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005679 Size: 5 KB 网页链接
美股滚雪球2023-01-03 08:34
在在COVID-19爆发后,生物制药行业迎来了发展利好,各项早期技术得到了涌入行业资金的支持,但随着美联储的加息步伐,医药板块开始从狂热走向了理性,不少医药公司陷入了困局,采取裁员、裁撤或出售管线、卖壳等自救措施(详见:凛冬之下:中小型药企的十大活法{凛冬之下:中小型药企的十...查看全文
littleluckybird2022-09-21 20:27
$Virios(VIRI)$ 哪位老师给评评,预测一下查看全文
闲散杂人2022-09-21 06:52
$Virios(VIRI)$ 2天时间,9元变5毛!!查看全文
股龍涅盤2022-09-21 02:34
chuminhua2022-09-20 11:19
9月19日,Virios Therapeutics 股价周一下跌多达 71%,此前该公司披露了顶线数据,表明其纤维肌痛候选药物 IMC-1 在 IIb 期试验中未能达到主要终点。该治疗是泛昔洛韦和塞来昔布的固定剂量组合,旨在抑制疱疹病毒复制,目的是减少病毒促进的疾病症状。
FORTRESS 研究招募了 422 名 18 至 65 岁...查看全文
鲜克有终72021-02-10 03:45
$Virios(VIRI)$ 等一个催化剂查看全文
Redboat882021-01-05 00:21
$Virios(VIRI)$
真是一路下跌啊,当初16.2卖的,现在回头看一身冷汗查看全文
被套与被罩2020-12-31 01:13
$Virios(VIRI)$ 7.52查看全文
利弗魔尔2020-12-24 04:09
$Virios(VIRI)$ 连续高换手,首日涨幅并不大,连续杀跌几天后依然活跃。7000多万市值,小而美,要成妖啊。这个换手想起活跃的$Luminar Technologies(LAZR)$ ,但上市涨幅小多了。抗病毒类免疫疗法,看能否被市场激活。查看全文
IPO收割机2020-12-18 05:31
$Virios(VIRI)$ 挂收盘买入 $16.71 入了1000股查看全文
$Virios(VIRI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007713 Act: 34 Size: 3 MB 网页链接
$Virios(VIRI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-007474 Act: 34 Size: 294 KB 网页链接
$Virios(VIRI)$ 8-K Current report, item 3.01 Accession Number: 0001558370-24-007096 Act: 34 Size: 162 KB 网页链接
$Virios(VIRI)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-054204 Act: 34 Size: 12 MB 网页链接
$Virios(VIRI)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005761 Act: 34 Size: 810 KB 网页链接
$Virios(VIRI)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002828 Act: 34 Size: 5 MB 网页链接
$Virios(VIRI)$ 8-K Current report, item 5.07 Accession Number: 0001558370-24-002613 Act: 34 Size: 175 KB 网页链接
$Virios(VIRI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002239 Act: 34 Size: 5 MB 网页链接
$Virios(VIRI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-002113 Act: 34 Size: 295 KB 网页链接
$Virios(VIRI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-005686 Size: 5 KB 网页链接